title: Severe rhabdomyolysis associated with raltegravir use.
authors.forename: Teresa R
authors.initials: TR
authors.lastname: Zembower
authors.forename: Lana
authors.initials: L
authors.lastname: Gerzenshtein
authors.forename: Karen
authors.initials: K
authors.lastname: Coleman
authors.forename: Frank J
authors.initials: FJ
authors.lastname: Palella
mesh_terms: D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects; D015658:HIV Infections / Q000188:drug therapy; D019428:HIV Integrase Inhibitors / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011760:Pyrrolidinones / Q000009:adverse effects*; D000068898:Raltegravir Potassium; D012206:Rhabdomyolysis / Q000139:chemically induced*
chemical_list: D019428:HIV Integrase Inhibitors; D011760:Pyrrolidinones; D000068898:Raltegravir Potassium